18 November 2021
ACCUSTEM SCIENCES LIMITED (‘Accustem UK’) and ACCUSTEM SCIENCES INC. (‘Accustem US’)
Interposition of new US holding company by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006
RESULTS OF SHAREHOLDER MEETINGS
Accustem UK is pleased to announce that at the Court Meeting and the General Meeting of Accustem UK Shareholders held earlier today to approve the terms of the interposition of a new US holding company be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the “Scheme”), the resolutions proposed were duly passed. Full details of the resolutions are set out in the notices of the Court Meeting and the General Meeting contained in the circular to Accustem UK Shareholders dated 2 November 2021 (the “Scheme Document”).
At the Court Meeting, a majority in number of Scheme Shareholders, who voted and were entitled to vote (either in person or by proxy on the virtual meeting platform) and who together represented over 75 per cent. by value of the votes cast, voted in favour of the resolution to approve the Scheme. The resolution was accordingly passed. At the General Meeting, the special resolutions to provide for the implementation of the Scheme and the amendments to Accustem UK’s articles of association were also passed by the requisite majority on a poll.
The results for the resolution to approve the Scheme were as follows: